Shire Anticipates Vyvanse Approval In “Next Month Or Two”
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm is considering a marketing partner and aims to replace its ADHD treatment Adderall XR with Vyvanse.
You may also be interested in...
Shire Anticipates Vyvanse Approval “Any Day”
Firm also announces plan to acquire Vyvanse partner New River Pharmaceuticals for $2.6 billion in cash.
Shire Anticipates Vyvanse Approval “Any Day”
Firm also announces plan to acquire Vyvanse partner New River Pharmaceuticals for $2.6 billion in cash.
Teva Generic Versions Of Focalin Clear FDA With 180-Day Exclusivity
The approval includes 2.5 mg, 5 mg and 10 mg formulations of dexmethylphenidate tabs for ADHD.